Interspecies comparison of the oral absorption of itraconazole in laboratory animals

The oral absorption and disposition of itraconazole were studied in rats, rabbits and dogs. Serum levels of itraconazole and its active metabolite, hydroxyitraconazole, were determined by a validated HPLC method. The absorption of itraconazole was relatively rapid in rats and dogs but was slower in rabbits. The terminal elimination half-life (T1/2λz), time to the peak con-centration (Tmax), dose and weight normalized area under the curve (AUC) and the peak concentration (Cmax) of itraconazole found in the dog were comparable to those reported in humans. As in humans, the metabolite to parent drug AUC ratios in rats and dogs were greater than unity but was less in rabbits. The dog appears to be an appropriate animal model while the rat, not the rabbit, may be used as an alternative animal model in predicting the oral absorption of itraconazole in humans.

[1]  R. Woestenborghs,et al.  The Clinical Pharmacokinetics of Itraconazole: An Overview , 1989, Mycoses.

[2]  N. Kaniwa,et al.  Gastric emptying of tablets and granules in humans, dogs, pigs, and stomach-emptying-controlled rabbits. , 1992, Journal of pharmaceutical sciences.

[3]  Anosh Joseph,et al.  Food interaction and steady-state pharmacokinetics of itraconazole capsules in healthy male volunteers , 1993, Antimicrobial Agents and Chemotherapy.

[4]  S. Clissold,et al.  Fluconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial and systemic mycoses. , 1990, Drugs.

[5]  M. Klausner,et al.  Effect of a Cola Beverage on the Bioavailability of Itraconazole in the Presence of H2 Blockers , 1997, Journal of clinical pharmacology.

[6]  A. Peer,et al.  The effects of food and dose on the oral systemic availability of itraconazole in healthy subjects , 2004, European Journal of Clinical Pharmacology.

[7]  J. Graybill,et al.  Pharmacokinetics of itraconazole following oral administration to normal volunteers , 1988, Antimicrobial Agents and Chemotherapy.

[8]  J. Dressman,et al.  Animal models for oral drug absorption , 1991 .

[9]  K. H. Lee,et al.  Absorption, first-pass metabolism, and disposition of itraconazole in rats. , 2000, Chemical & pharmaceutical bulletin.

[10]  S. Riegelman,et al.  Complications in using rabbits for the study of oral drug absorption. , 1969, Chemical & pharmaceutical bulletin.

[11]  R. Woestenborghs,et al.  Pharmacokinetics of oral antifungals and their clinical implications. , 1990, British journal of clinical practice. Supplement.

[12]  J. Levron,et al.  The pharmacokinetics of itraconazole in animals and man: an overview , 1987 .

[13]  Tim Morris,et al.  Physiological Parameters in Laboratory Animals and Humans , 1993, Pharmaceutical Research.

[14]  K. Goa,et al.  Itraconazole. A reappraisal of its pharmacological properties and therapeutic use in the management of superficial fungal infections. , 1996, Drugs.

[15]  B. Dupont,et al.  Early experience with itraconazole in vitro and in patients: pharmacokinetic studies and clinical results. , 1987, Reviews of infectious diseases.

[16]  R. Yeates,et al.  Influence of concomitant food intake on the gastrointestinal absorption of fluconazole and itraconazole in Japanese subjects. , 1994, International journal of clinical pharmacology research.